HYDROXYCHLOROQUINE SULFATE Drug Patent Profile
✉ Email this page to a colleague
When do Hydroxychloroquine Sulfate patents expire, and when can generic versions of Hydroxychloroquine Sulfate launch?
Hydroxychloroquine Sulfate is a drug marketed by Accord Hlthcare, Alkaloida Zrt, Amneal Pharms Co, Appco, Aurobindo Pharma Usa, Chartwell Rx, Creekwood Pharms, Hikma Pharms, Ipca Labs Ltd, Laurus, Sandoz, Senores Pharms, Teva Pharms, Watson Labs, and Zydus Pharms Usa Inc. and is included in fifteen NDAs.
The generic ingredient in HYDROXYCHLOROQUINE SULFATE is hydroxychloroquine sulfate. There are fifteen drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the hydroxychloroquine sulfate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Hydroxychloroquine Sulfate
A generic version of HYDROXYCHLOROQUINE SULFATE was approved as hydroxychloroquine sulfate by TEVA PHARMS on September 30th, 1994.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for HYDROXYCHLOROQUINE SULFATE?
- What are the global sales for HYDROXYCHLOROQUINE SULFATE?
- What is Average Wholesale Price for HYDROXYCHLOROQUINE SULFATE?
Summary for HYDROXYCHLOROQUINE SULFATE
| US Patents: | 0 |
| Applicants: | 15 |
| NDAs: | 15 |
| Finished Product Suppliers / Packagers: | 25 |
| Raw Ingredient (Bulk) Api Vendors: | 122 |
| Clinical Trials: | 46 |
| Patent Applications: | 2,399 |
| Drug Sales Revenues: | Drug sales revenues for HYDROXYCHLOROQUINE SULFATE |
| What excipients (inactive ingredients) are in HYDROXYCHLOROQUINE SULFATE? | HYDROXYCHLOROQUINE SULFATE excipients list |
| DailyMed Link: | HYDROXYCHLOROQUINE SULFATE at DailyMed |
Recent Clinical Trials for HYDROXYCHLOROQUINE SULFATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Henan Cancer Hospital | Phase 2 |
| West Virginia University | Phase 1/Phase 2 |
| Johns Hopkins University | Phase 2 |
Pharmacology for HYDROXYCHLOROQUINE SULFATE
| Drug Class | Antimalarial Antirheumatic Agent |
Medical Subject Heading (MeSH) Categories for HYDROXYCHLOROQUINE SULFATE
Anatomical Therapeutic Chemical (ATC) Classes for HYDROXYCHLOROQUINE SULFATE
US Patents and Regulatory Information for HYDROXYCHLOROQUINE SULFATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accord Hlthcare | HYDROXYCHLOROQUINE SULFATE | hydroxychloroquine sulfate | TABLET;ORAL | 213342-002 | Aug 18, 2021 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Senores Pharms | HYDROXYCHLOROQUINE SULFATE | hydroxychloroquine sulfate | TABLET;ORAL | 212902-001 | May 14, 2020 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Appco | HYDROXYCHLOROQUINE SULFATE | hydroxychloroquine sulfate | TABLET;ORAL | 210441-002 | Sep 19, 2022 | AB | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
